Partnering and Business Development
BioAgency AG, Hamburg is a private company with individual and institutional shareholders from Germany and German-speaking countries. BioAgency's shareholders appreciate the opportunities but also the risks of being engaged in the life sciences industry and they have always been aware of the time needs and costs associated with developments in this industry. Besides being financial investors, BioAgency's shareholders provide support to their company bringing in knowledge and experience.
BioAgency's main focus is to invest in and carry out development projects.
They identify and select developments of products, product candidates, technologies and services of the life sciences with the aim of bringing them to the market. These projects originate from academia from biotech or medtech companies and from the pharmaceutical industry and are further developed in collaboration. They subsequently licence these developments out to companies that are able to achieve approval and bring them to the marketplace.
So far they have conducted and out-licenced developments in the areas of oncology, infectious diseases, neurodegenerative disorders, cardiovascular diseases, surgery, orthopedics and diagnostics.